MicroRNA enzyme immunoassay
BioVendor has now launched hsa-miR-21-5p miREIA, a quantitative assay combining molecular diagnostics and immunoassay technology. MiRNA isolated from a patient sample is hybridized to a complementary biotinylated DNA oligonucleotide probe. The miRNA/DNA hybrids are then processed in an ELISA format in a microtitre plate coated with a monoclonal antibody specific to perfectly matched miRNA/DNA dimers. The miREIA kits have been designed to quantify circulating miRNA from whole blood, enabling investigators to explore these promising biomarkers in various conditions including cancer, cardiovascular diseases, pulmonary diseases, regulation of immunological processes, reliably and in an easy-to-use format.
Supplier: BioVendor Research and Diagnostic Products
Website:
